Perspectives in head and neck cancer
β Scribed by Alando J. Ballantyne
- Book ID
- 115694249
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 237 KB
- Volume
- 150
- Category
- Article
- ISSN
- 0002-9610
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Disease management of head and neck cancer has improved significantly. However, a high rate of early recurrences and metastasis still counteract improvement of longβterm survival. Hence, the quest for molecular mechanisms and key regulatory factors exploitable by targeted therapies is s
## Abstract The epidermal growth factor receptor (EGFR) has been shown to be a promising therapeutic target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been approved in the United States for use with radiotherapy for head and neck squamous cell carcinoma. However, th